Delivery Order SPE2DB20D1100-SPE2DB25FE0T6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,193.61 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) with a firm fixed price structure and an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $48,497.72 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $33,700.47 for NURTEC ODT 75 mg tablets (8-count units) on August 25, 2025, with completion anticipated by August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,555.23 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,304.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,630.69 on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $17,366.42 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency (DLA) awarded a $17,326.95 delivery order contract to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.999 billion ceiling value through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,948.56 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0T6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,606.70 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This competitively awarded, firm fixed-price contract reflects no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. NURTEC ODT is a migraine treatment medication, and this delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain. As the prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen demonstrates ongoing capability to fulfill federal procurement requirements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a key medical supply partner for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/14/25 |